Overcoming Study-Patient Burdens in Medical Research During the Pandemic

Study-patient recruitment and retention continue to be significant challenges in medical research, and even more so, during the COVID-19 pandemic. The at-home isolation and social distancing orders for millions of Americans is a vital element to slow the COVID-19 pandemic, but the global pandemic has the potential to disrupt and delay vital research. In order to assist the research community in navigating these unprecedented times, The Food and Drug Administration (FDA) has issued new guidance in continuing medical research during the global pandemic to ensure the safety of trial participants and study personnel while maintaining research integrity.

Read the entire artcile here: Pharmaceutical Outsourcing